TP53 and cancer: Genomic analysis (gene panel sequencing and copy-number microarray) demonstrated a novel p.Phe338Leu tetramerisation domain (TD) <i>TP53</i> variant in the proband and his cancer-free mother and a monoallelic deletion encompassing the <i>TP53</i> locus in cancer tissue, consistent with cancer-predisposition syndrome.